Investing.com - H.C. Wainwright raised its price target on Axsome Therapeutics (NASDAQ:AXSM) to $200.00 from $185.00 on Monday, while maintaining a Buy rating on the stock. The company’s shares have ...
— NDA supported by results from a Phase II registration trial in China — — Second most common form of liver cancer after hepatocellular carcinoma, with generally poorer long-term survival in ...
VIRGINIA BEACH, Va. — Virginia Beach EMS implemented a new policy limiting the use of lights and sirens on Priority 2 calls. Chief Jason Stroud said the change, implemented in late October, aligns ...
VIRGINIA BEACH, Va. — This week, an operational change went into effect for Virginia Beach EMS in which first responders will limit the utilization of lights and sirens for calls under their Priority ...
Kate Farmer ably reports that “The Navy at 250 Faces New Challenges” (op-ed, Oct. 13). Secretary John Phelan told our colleagues in the House this summer that our programs are “a mess,” “behind ...
The Beaumont City Council received an update on the Pennsylvania Avenue Grade Separation project, which has been underway since June 2018. Public Works Director Robert Vestal discussed the progress ...
Investors considering a purchase of Array Technologies Inc (Symbol: ARRY) stock, but tentative about paying the going market price of $7.12/share, might benefit from considering selling puts among the ...
The Athletic has live coverage of the 2025 NBA free agency. The NBA Draft was another opportunity for the LA Clippers to utilize their new home, the Intuit Dome, in unforeseen ways. This time a year ...
DENVER, May 01, 2025 (GLOBE NEWSWIRE) -- Gravitee, the leading Agentic API and Event Management company, announces the results of a survey on the use of Agentic AI systems and Large Language Models ...
Tied up in environmental and court appeals, native title and regulatory red tape for more than a decade, the Resolution Copper mine is among a handful of 10 projects granted ‘‘Fast-41’’ status by the ...
It is well established that “a petitioner in an inter partes review … is not permitted to assert a ground of unpatentability under 35 U.S.C. § 112.” Dexcowin Golabl, Inc. v. Aribex, Inc., ...